Mechanisms of adult human β‐cell in vitro dedifferentiation and redifferentiation

Publisher: John Wiley & Sons Inc

E-ISSN: 1463-1326|18|S1|97-101

ISSN: 1462-8902

Source: DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.18, Iss.S1, 2016-09, pp. : 97-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Recent studies in animal models and human pathological specimens suggest the involvement of β‐cell dedifferentiation in β‐cell dysfunction associated with type 2 diabetes. Dedifferentiated β‐cells may be exploited for endogenous renewal of the β‐cell mass. However, studying human β‐cell dedifferentiation in diabetes presents major difficulties. We have analysed mechanisms involved in human β‐cell dedifferentiation in vitro, under conditions that allow cell proliferation. Although there are important differences between the two cellular environments, β‐cell dedifferentiation in the two conditions is likely to share a number of common pathways. Insights from the in vitro studies may lead to development of approaches for redifferentiation of endogenous dedifferentiated β‐cells.